Physician profile
James M Randle
NPI 1457460370
$252,529.51
in general payments reported to CMS, 2019-2025
6 companies · $8,206 in 2025
The $8,206 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $41K · 2021: $30K · 2022: $39K · 2023: $68K · 2024: $10K · 2025: $8,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $44K · Consulting Fee: $42K · Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $44,479.44 |
| Consulting Fee | $41,500.00 |
| Food and Beverage | $911.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $209,140.91 | 2019-2023 | Spira |
| Ctl Medical Corporation | $41,852.74 | 2022-2025 | Spinal, Raphael Pedicle Screw System |
| Wenzel Spine, INC. | $1,475.49 | 2021-2025 | Varilift, Varilift |
| Nuvasive, INC. | $29.62 | 2019 | |
| Depuy Synthes Sales INC. | $17.07 | 2023 | Cranioplastic |
| Stryker Corporation | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Randle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.